{"id":1055,"date":"2025-02-12T14:58:00","date_gmt":"2025-02-12T19:58:00","guid":{"rendered":"https:\/\/usesparrow.com\/blog\/?p=1055"},"modified":"2025-08-21T05:57:34","modified_gmt":"2025-08-21T09:57:34","slug":"walgreens-prescription-savings-club-class-action-settlement","status":"publish","type":"post","link":"https:\/\/usesparrow.com\/blog\/walgreens-prescription-savings-club-class-action-settlement\/","title":{"rendered":"$100M Walgreens Class Action Settlement: How To File A Claim"},"content":{"rendered":"\n

Walgreens has agreed to pay $100 million<\/a><\/strong> to settle a class action lawsuit alleging that it overcharged Prescription Savings Club (PSC) members<\/strong> by falsely inflating drug prices. This settlement aims to compensate affected consumers and bring clarity to the pharmacy’s pricing practices. Here\u2019s everything you need to know about the case, who qualifies for compensation, and how to file a claim.<\/p>\n\n\n\n

Background of the Walgreens Settlement<\/h2>\n\n\n\n

The lawsuit claims that Walgreens misled customers enrolled in its Prescription Savings Club (PSC)<\/strong> by charging inflated prices<\/strong> for prescription medications. Plaintiffs argue that Walgreens failed to apply its internal discount program, leading PSC members to pay more than they should have.<\/p>\n\n\n\n

Walgreens, one of the largest pharmacy chains in the U.S., has denied any wrongdoing but agreed to a $100 million settlement<\/strong> to resolve the allegations and avoid further litigation. The lawsuit alleged that Walgreens violated consumer protection laws<\/strong> and engaged in unfair business practices<\/strong> by misrepresenting drug prices.<\/p>\n\n\n\n

This case is part of a broader movement to hold pharmacies accountable for pricing transparency and ensuring customers receive fair discounts. The settlement brings relief to customers who unknowingly overpaid for medications through the program.<\/p>\n\n\n\n

This lawsuit, Doe, et al. v. Walgreens Co., Case No. 1:22-cv-04775<\/strong>, was filed in the U.S. District Court for the Northern District of Illinois<\/strong>. The plaintiffs argued that Walgreens engaged in deceptive pricing tactics that violated consumer trust and financial fairness. The case gained national attention, highlighting the need for increased transparency in prescription drug pricing.<\/p>\n\n\n\n

If you are unsure whether you qualify, review the FAQ section<\/strong> of the official settlement website or consult a legal professional.<\/p>\n\n\n\n

Who Is Eligible for Compensation?<\/h2>\n\n\n\n

The settlement applies to consumers who enrolled in the Walgreens Prescription Savings Club between Jan. 1, 2007, and Dec. 31, 2022, and paid out-of-pocket for medications that should have been discounted.<\/strong><\/p>\n\n\n\n

Eligible class members can receive a cash payment based on their out-of-pocket expenses for covered prescriptions.<\/p>\n\n\n\n

How Much Can You Receive?<\/h3>\n\n\n\n

The settlement offers compensation based on how much each individual overpaid:<\/p>\n\n\n\n